Inhibition of CDK/Cyclin-phospho-Rb signaling by amebaciclib may have an antitumor effect against uterine leiomyosarcoma
- DOI
- 10.1038/s41392-026-02983-z
- Published
- 2026-09-21
- Container
- Signal Transduction and Targeted Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41392-026-02983-z,
title = {Inhibition of CDK/Cyclin-phospho-Rb signaling by amebaciclib may have an antitumor effect against uterine leiomyosarcoma},
author = {Takuma Hayashi and Manabu Muto and Ikuo Konishi},
year = {2026},
journal = {Signal Transduction and Targeted Therapy},
doi = {10.1038/s41392-026-02983-z},
url = {https://doi.org/10.1038/s41392-026-02983-z}
}RIS
TY - JOUR TI - Inhibition of CDK/Cyclin-phospho-Rb signaling by amebaciclib may have an antitumor effect against uterine leiomyosarcoma AU - Takuma Hayashi AU - Manabu Muto AU - Ikuo Konishi PY - 2026 JO - Signal Transduction and Targeted Therapy DO - 10.1038/s41392-026-02983-z UR - https://doi.org/10.1038/s41392-026-02983-z ER -
APA
Hayashi, T., Muto, M., & Konishi, I. (2026). Inhibition of CDK/Cyclin-phospho-Rb signaling by amebaciclib may have an antitumor effect against uterine leiomyosarcoma. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-026-02983-z
Source records
- crossref · retrieved 2026-09-26T06:40:05.283Z